Results 221 to 230 of about 290,882 (260)

Hypersomnia in major depressive disorders

Journal of Affective Disorders, 1984
Hypersomnia was experienced by 17 of 102 patients with major depressive disorder. Comparisons between hypersomnic and non-hypersomnic depressives demonstrated significant associations between hypersomnia and increased appetite, weight gain, agitation, headaches, depression in a first-degree relative, and earlier age of illness onset.
M J, Garvey, D, Mungas, G D, Tollefson
openaire   +2 more sources

MicroRNAs in Major Depressive Disorder

2019
Major depressive disorder (MDD) is a severe and chronic psychiatric disorder with a high prevalence in the population. Although our understanding of its pathophysiological mechanisms has significantly increased over the years, available treatments still present several limitations and are not effective to all MDD patients.
Gabriel R, Fries, Wei, Zhang, Deborah, Benevenuto, Joao, Quevedo   +3 more
openaire   +2 more sources

Subcortical volumes differentiate Major Depressive Disorder, Bipolar Disorder, and remitted Major Depressive Disorder

Journal of Psychiatric Research, 2015
Subcortical gray matter regions have been implicated in mood disorders, including Major Depressive Disorder (MDD) and Bipolar Disorder (BD). It is unclear, however, whether or how these regions differ among mood disorders and whether such abnormalities are state- or trait-like.
Matthew D, Sacchet, Emily E, Livermore, Juan Eugenio, Iglesias, Gary H, Glover, Ian H, Gotlib   +4 more
openaire   +2 more sources

Major Depression, Double Depression and Personality Disorders

Journal of Personality Disorders, 2000
Personality disorders are much more common among depressive patients than among normal people. Until now, little research has been conducted into the prevalence of personality disorders among patients with both major depression and dysthymia (double depression).
S, Kool, J, Dekker, I J, Duijsens, F, de Jonghe   +3 more
openaire   +2 more sources

Seltorexant for major depressive disorder

Expert Opinion on Emerging Drugs
Preclinical and clinical pharmacologic evidence indicates that orexin systems are relevant to sleep-wake cycle regulation and dimensions of reward and cognition, providing the basis for hypothesizing that they may be effective as therapeutics in mental disorders.
Kyle, Valentino, Kayla M, Teopiz, Sabrina, Wong, Melanie C, Zhang, Gia Han, Le, Hayun, Choi, Hana, Ballum, Christine, Dri, William, Cheung, Roger S, McIntyre   +9 more
openaire   +2 more sources

Major Depression, Dysthymia and Depressive Personality Disorder

British Journal of Psychiatry, 1994
The separation of persistent depression into meaningful and useful subcategories, including major depression, dysthymia, recurrent brief depression, and depressive personality disorder, is the subject of much debate. Depressions can be grouped on the basis of their type and severity of symptoms, aetiology, clinical course, or their association with ...
openaire   +2 more sources

Major Depressive Disorder

2012
Chapter 4 describes a case of IPT treatment of major depressive disorder with a focus on role transitions, and how social roles are central to our sense of identity, how all individuals may hold numerous roles (partner, child, parent, sibling, neighbor, community member, etc.), besides having vocational roles (colleague, employee, employer, or ...
Paula Ravitz, Robert Maunder
openaire   +1 more source

Major Depressive Disorder

2014
Depression affects about 121 million people worldwide and is characterized by episodes of affective, somatic, cognitive, and motivational symptoms generally expressed by loss of interest and pleasure with increasing functional impairment, morbidity, and mortality.
Donatella Marazziti, Grazia Rutigliano, Stefano Baroni, Liliana Dell’Osso   +3 more
openaire   +1 more source

Major depressive disorder

JAAPA, 2020
openaire   +2 more sources

A Scientometrics Analysis and Visualization of Depressive Disorder

Current Neuropharmacology, 2021
Dong Xu, Yuan-Lu Cui
exaly